Industry: Chemical & Material
Published Date: 2026-04-18
Pages: 133 Pages
Report ld: 6500236
Request Sample
Customized Report
D-Amphetamine Sulfate API Market Size(US$)

CAGR 2026-2032
4.8%
Market Size,2032
USD 84.23
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global D-Amphetamine Sulfate API market was valued at US$ 60.94 million in 2025 and is anticipated to reach US$ 84.23 million by 2032, at a CAGR of 4.8% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on D-Amphetamine Sulfate API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
D-Amphetamine Sulfate is a central nervous system (CNS) stimulant and an amphetamine enantiomer that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by changing the amounts of certain natural substances in the brain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
D-Amphetamine Sulfate API is a crucial raw material for neuroregulatory drugs, widely used in the treatment of neurological and psychiatric disorders like Attention Deficit Hyperactivity Disorder (ADHD). As the focus on neural health continues to grow, the market demand is steadily increasing. The market size is expanding, with consistent growth in sales. Furthermore, the specific uses of D-Amphetamine Sulfate are diversifying, including its illicit misuse in the realm of sports and athletics. In the future, with advancements in technology and healthcare, the D-Amphetamine Sulfate API is poised to play a more significant role in the treatment of a broader range of neurological and psychiatric disorders.
This report delivers a comprehensive overview of the global D-Amphetamine Sulfate API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding D-Amphetamine Sulfate API. The D-Amphetamine Sulfate API market size, estimates, and forecasts are provided in terms of output/shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global D-Amphetamine Sulfate API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist D-Amphetamine Sulfate API manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for D-Amphetamine Sulfate API manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines D-Amphetamine Sulfate API production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes D-Amphetamine Sulfate API consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 D-Amphetamine Sulfate API Market Overview
1.1 Product Definition
1.2 D-Amphetamine Sulfate API by Type
1.2.1 Global D-Amphetamine Sulfate API Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 USP
1.2.3 EP
1.3 D-Amphetamine Sulfate API by Application
1.3.1 Global D-Amphetamine Sulfate API Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Attention Deficit Hyperactivity Disorder
1.3.3 Narcolepsy
1.3.4 Other
1.4 Global Market Growth Prospects
1.4.1 Global D-Amphetamine Sulfate API Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global D-Amphetamine Sulfate API Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global D-Amphetamine Sulfate API Production Estimates and Forecasts (2021–2032)
1.4.4 Global D-Amphetamine Sulfate API Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global D-Amphetamine Sulfate API Production Market Share by Manufacturers (2021–2026)
2.2 Global D-Amphetamine Sulfate API Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of D-Amphetamine Sulfate API, Industry Ranking, 2024 vs 2025
2.4 Global D-Amphetamine Sulfate API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global D-Amphetamine Sulfate API Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of D-Amphetamine Sulfate API, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of D-Amphetamine Sulfate API, Product Offerings and Applications
2.8 Global Key Manufacturers of D-Amphetamine Sulfate API, Date of Entry into the Industry
2.9 D-Amphetamine Sulfate API Market Competitive Situation and Trends
2.9.1 D-Amphetamine Sulfate API Market Concentration Rate
2.9.2 Top 5 and Top 10 Global D-Amphetamine Sulfate API Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 D-Amphetamine Sulfate API Production by Region
3.1 Global D-Amphetamine Sulfate API Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global D-Amphetamine Sulfate API Production Value by Region (2021–2032)
3.2.1 Global D-Amphetamine Sulfate API Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of D-Amphetamine Sulfate API by Region (2027–2032)
3.3 Global D-Amphetamine Sulfate API Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global D-Amphetamine Sulfate API Production Volume by Region (2021–2032)
3.4.1 Global D-Amphetamine Sulfate API Production by Region (2021–2026)
3.4.2 Global Forecasted Production of D-Amphetamine Sulfate API by Region (2027–2032)
3.5 Global D-Amphetamine Sulfate API Market Price Analysis by Region (2021–2032)
3.6 Global D-Amphetamine Sulfate API Production, Value, and Year-over-Year Growth
3.6.1 North America D-Amphetamine Sulfate API Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe D-Amphetamine Sulfate API Production Value Estimates and Forecasts (2021–2032)
3.6.3 China D-Amphetamine Sulfate API Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan D-Amphetamine Sulfate API Production Value Estimates and Forecasts (2021–2032)
4 D-Amphetamine Sulfate API Consumption by Region
4.1 Global D-Amphetamine Sulfate API Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global D-Amphetamine Sulfate API Consumption by Region (2021–2032)
4.2.1 Global D-Amphetamine Sulfate API Consumption by Region (2021–2026)
4.2.2 Global D-Amphetamine Sulfate API Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America D-Amphetamine Sulfate API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America D-Amphetamine Sulfate API Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe D-Amphetamine Sulfate API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe D-Amphetamine Sulfate API Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific D-Amphetamine Sulfate API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific D-Amphetamine Sulfate API Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa D-Amphetamine Sulfate API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa D-Amphetamine Sulfate API Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global D-Amphetamine Sulfate API Production by Type (2021–2032)
5.1.1 Global D-Amphetamine Sulfate API Production by Type (2021–2026)
5.1.2 Global D-Amphetamine Sulfate API Production by Type (2027–2032)
5.1.3 Global D-Amphetamine Sulfate API Production Market Share by Type (2021–2032)
5.2 Global D-Amphetamine Sulfate API Production Value by Type (2021–2032)
5.2.1 Global D-Amphetamine Sulfate API Production Value by Type (2021–2026)
5.2.2 Global D-Amphetamine Sulfate API Production Value by Type (2027–2032)
5.2.3 Global D-Amphetamine Sulfate API Production Value Market Share by Type (2021–2032)
5.3 Global D-Amphetamine Sulfate API Price by Type (2021–2032)
6 Segment by Application
6.1 Global D-Amphetamine Sulfate API Production by Application (2021–2032)
6.1.1 Global D-Amphetamine Sulfate API Production by Application (2021–2026)
6.1.2 Global D-Amphetamine Sulfate API Production by Application (2027–2032)
6.1.3 Global D-Amphetamine Sulfate API Production Market Share by Application (2021–2032)
6.2 Global D-Amphetamine Sulfate API Production Value by Application (2021–2032)
6.2.1 Global D-Amphetamine Sulfate API Production Value by Application (2021–2026)
6.2.2 Global D-Amphetamine Sulfate API Production Value by Application (2027–2032)
6.2.3 Global D-Amphetamine Sulfate API Production Value Market Share by Application (2021–2032)
6.3 Global D-Amphetamine Sulfate API Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Veranova
7.1.1 Veranova D-Amphetamine Sulfate API Company Information
7.1.2 Veranova D-Amphetamine Sulfate API Product Portfolio
7.1.3 Veranova D-Amphetamine Sulfate API Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Veranova Main Business and Markets Served
7.1.5 Veranova Recent Developments/Updates
7.2 Cambrex
7.2.1 Cambrex D-Amphetamine Sulfate API Company Information
7.2.2 Cambrex D-Amphetamine Sulfate API Product Portfolio
7.2.3 Cambrex D-Amphetamine Sulfate API Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Cambrex Main Business and Markets Served
7.2.5 Cambrex Recent Developments/Updates
7.3 Curia Global
7.3.1 Curia Global D-Amphetamine Sulfate API Company Information
7.3.2 Curia Global D-Amphetamine Sulfate API Product Portfolio
7.3.3 Curia Global D-Amphetamine Sulfate API Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Curia Global Main Business and Markets Served
7.3.5 Curia Global Recent Developments/Updates
7.4 Mallinckrodt Pharmaceuticals
7.4.1 Mallinckrodt Pharmaceuticals D-Amphetamine Sulfate API Company Information
7.4.2 Mallinckrodt Pharmaceuticals D-Amphetamine Sulfate API Product Portfolio
7.4.3 Mallinckrodt Pharmaceuticals D-Amphetamine Sulfate API Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Mallinckrodt Pharmaceuticals Main Business and Markets Served
7.4.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
7.5 Axyntis Group
7.5.1 Axyntis Group D-Amphetamine Sulfate API Company Information
7.5.2 Axyntis Group D-Amphetamine Sulfate API Product Portfolio
7.5.3 Axyntis Group D-Amphetamine Sulfate API Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Axyntis Group Main Business and Markets Served
7.5.5 Axyntis Group Recent Developments/Updates
7.6 Chattem Chemicals
7.6.1 Chattem Chemicals D-Amphetamine Sulfate API Company Information
7.6.2 Chattem Chemicals D-Amphetamine Sulfate API Product Portfolio
7.6.3 Chattem Chemicals D-Amphetamine Sulfate API Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Chattem Chemicals Main Business and Markets Served
7.6.5 Chattem Chemicals Recent Developments/Updates
7.7 Chr. Olesen
7.7.1 Chr. Olesen D-Amphetamine Sulfate API Company Information
7.7.2 Chr. Olesen D-Amphetamine Sulfate API Product Portfolio
7.7.3 Chr. Olesen D-Amphetamine Sulfate API Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Chr. Olesen Main Business and Markets Served
7.7.5 Chr. Olesen Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 D-Amphetamine Sulfate API Industry Chain Analysis
8.2 D-Amphetamine Sulfate API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 D-Amphetamine Sulfate API Production Modes and Processes
8.4 D-Amphetamine Sulfate API Sales and Marketing
8.4.1 D-Amphetamine Sulfate API Sales Channels
8.4.2 D-Amphetamine Sulfate API Distributors
8.5 D-Amphetamine Sulfate API Customer Analysis
9 D-Amphetamine Sulfate API Market Dynamics
9.1 D-Amphetamine Sulfate API Industry Trends
9.2 D-Amphetamine Sulfate API Market Drivers
9.3 D-Amphetamine Sulfate API Market Challenges
9.4 D-Amphetamine Sulfate API Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for D-Amphetamine Sulfate API was estimated to be worth US$ 60.94 million in 2025 and is projected to reach US$ 84.23 million, growing at a CAGR of 4.8% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 129
USD 3950.00
(Single User License)
The global D-Amphetamine Sulfate API market size was US$ 58.4 million in 2024 and is forecast to a readjusted size of US$ 80.7 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 79
USD 4250.00
(Single User License)
The global D-Amphetamine Sulfate API market is projected to grow from US$ 58.4 million in 2024 to US$ 80.7 million by 2031, at a CAGR of 4.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 140
USD 4900.00
(Single User License)
The global market for D-Amphetamine Sulfate API was estimated to be worth US$ 58.4 million in 2024 and is forecast to a readjusted size of US$ 80.7 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 110
USD 3950.00
(Single User License)
The global market for D-Amphetamine Sulfate API was valued at US$ 58.4 million in the year 2024 and is projected to reach a revised size of US$ 80.7 million by 2031, growing at a CAGR of 4.8% during the forecast period.
Published Date: 2025-01-16
Pages: 86
USD 2900.00
(Single User License)
D-Amphetamine Sulfate is a central nervous system (CNS) stimulant and an amphetamine enantiomer that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by changing the amounts of certain natural substances in the brain.
Published Date: 2024-04-15
Pages: 92
USD 4900.00
(Single User License)
D-Amphetamine Sulfate is a central nervous system (CNS) stimulant and an amphetamine enantiomer that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by changing the amounts of certain natural substances in the brain.
Published Date: 2024-01-18
Pages: 94
USD 2900.00
(Single User License)
D-Amphetamine Sulfate is a central nervous system (CNS) stimulant and an amphetamine enantiomer that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by changing the amounts of certain natural substances in the brain.
Published Date: 2024-01-15
Pages: 93
USD 3950.00
(Single User License)
The global market for D-Amphetamine Sulfate API was estimated to be worth US$ 60.94 million in 2025 and is projected to reach US$ 84.23 million, growing at a CAGR of 4.8% from 2026 to 2032.
Published: 2026-06-16
Pages: 129
The global D-Amphetamine Sulfate API market size was US$ 58.4 million in 2024 and is forecast to a readjusted size of US$ 80.7 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 79
The global D-Amphetamine Sulfate API market is projected to grow from US$ 58.4 million in 2024 to US$ 80.7 million by 2031, at a CAGR of 4.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 140
The global market for D-Amphetamine Sulfate API was estimated to be worth US$ 58.4 million in 2024 and is forecast to a readjusted size of US$ 80.7 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 110
The global market for D-Amphetamine Sulfate API was valued at US$ 58.4 million in the year 2024 and is projected to reach a revised size of US$ 80.7 million by 2031, growing at a CAGR of 4.8% during the forecast period.
Published: 2025-01-16
Pages: 86
D-Amphetamine Sulfate is a central nervous system (CNS) stimulant and an amphetamine enantiomer that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by changing the amounts of certain natural substances in the brain.
Published: 2024-04-15
Pages: 92
D-Amphetamine Sulfate is a central nervous system (CNS) stimulant and an amphetamine enantiomer that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by changing the amounts of certain natural substances in the brain.
Published: 2024-01-18
Pages: 94
D-Amphetamine Sulfate is a central nervous system (CNS) stimulant and an amphetamine enantiomer that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by changing the amounts of certain natural substances in the brain.
Published: 2024-01-15
Pages: 93
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now